2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

In Vivo Expansion of Donor-Specific Regulatory T Cells by a New Triazolopyrimidine Derivative and Donor-Specific Transfusion

S. Emoto,¹ R. Goto,¹ S. Shibasaki,¹ A. Nagatsu,¹ H. Ono,¹ R. Igarashi,¹ M. Fukai,² T. Shimamura,³ K. Saiga,⁴ M. Murakami,⁵ A. Taketomi,¹ S. Todo,⁶ K. Yamashita.²
Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients

J. Bank,¹ M. Mallat,¹ P. van der Boog,¹ D. Braat,² J. Ringers,² M. Vergunst,³ S. Heidt,³ F. Claas,³ M. Reinders,¹ J. de Fijter.¹
Incidence and Characteristics of CMV Infection in High Risk (D+R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis

M. Bhattarai, C. Puttarajappa, G. Mour, C. Wu, P. Sood, N. Shah, R. Mehta, A. Tevar, S. Hariharan.
Incidence and Clinical Severity of Hypogammaglobulinemia (Hypo-IgG) in Highly-HLA Sensitized Patients (HS) Undergoing Desensitization (DES)

A. Vo,¹ S. Ge,² A. Petrosyan,² M. Toyoda,² J. Choi,¹ J. Kahwaji,¹ A. Peng,¹ R. Villicana,¹ S. Jordan.¹
Incidence and Impact of De Novo Donor-Specific Anti-HLA Antibodies in ABO-Compatible Liver-Transplant Recipients

A. Del Bello,^1,2 N. Congy-Jolivet,^2,3,4 D. Milongo,¹ C. Guilbeau-Frugier,^2,5 L. Lavayssière,¹ F. Muscari,^2,6 L. Rostaing,^1,2,7 N. Kamar.^1,2,7
Incidence and Outcomes of Polyomavirus Infection in 639 Kidney Transplant Recipients: Are High Immunological Risk Characteristics More Relevant Than Specific Induction Or Maintenance Immunosuppressive Regimens?

E. Favi,¹ L. Harris,² J. Worsfold,² R. Cacciola,¹ C. Puliatti,¹ C. Sammartino,¹ R. Sivaprakasam.¹
Incidence and Risk Factors for Emergency Department Visits Following Kidney Transplantation

N. Elfadawy,^1,2 E. Poggio,¹ D. Goldfarb,¹ L. Buccini,¹ S. Flechner,¹ J. Schold.¹
Incidence and Risk Factors for Infectious Complications in Liver Transplant Patients Converted to Everolimus

A. Islam,¹ J. DeVos,² L. Teeter,³ E. Graviss,³ S. Gordon-Burroughs,¹ A. Saharia,¹ C. Mobley,¹ A. Gaber,¹ R. Ghobrial.¹
Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients

B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.
Incidence and Risks Associated With Clostridium Difficile Infection in the Pediatric Solid Organ Transplantation Population: A Single-Center Retrospective Review

L. Danziger-Isakov,¹ J. Ciricillo,² S. Blum,¹ M.-O. Kim,¹ C. Liu,¹ G. Paulsen,¹ J. Courter,¹ D. Haslam.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z